LaFleur & Godfrey LLC Sells 1,187 Shares of Intuitive Surgical, Inc. $ISRG

LaFleur & Godfrey LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 61.7% during the third quarter, HoldingsChannel reports. The firm owned 736 shares of the medical equipment provider’s stock after selling 1,187 shares during the quarter. LaFleur & Godfrey LLC’s holdings in Intuitive Surgical were worth $329,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Tobam raised its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. bought a new stake in shares of Intuitive Surgical during the third quarter worth $27,000. Guerra Advisors Inc acquired a new stake in shares of Intuitive Surgical during the third quarter worth $37,000. Finally, Riggs Asset Managment Co. Inc. raised its holdings in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after acquiring an additional 32 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $504.05 on Monday. The stock’s 50-day simple moving average is $535.88 and its 200 day simple moving average is $511.00. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $607.35. The company has a market cap of $179.00 billion, a P/E ratio of 63.88, a P/E/G ratio of 3.90 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period last year, the company earned $2.21 earnings per share. The business’s revenue was up 18.8% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Evercore cut their price target on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Argus dropped their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Finally, TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Insider Activity

In related news, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 56,189 shares of company stock valued at $30,785,441 over the last three months. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.